M344 Suppresses Histone Deacetylase-Associated Phenotypes and Tumor Growth in Neuroblastoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Neuroblastoma (NB) is a pediatric cancer. The novel HDAC inhibitor M344 shows promise, effectively reducing tumor growth and improving survival with fewer toxicities than current treatments.
Area Of Science
- Oncology
- Molecular Biology
- Pharmacology
Background
- Neuroblastoma (NB) is an aggressive pediatric cancer with poor survival rates for high-risk patients.
- Standard NB therapies cause toxicities and relapse, necessitating novel therapeutic strategies.
- Histone deacetylase (HDAC) inhibitors modulate gene expression and tumor phenotypes, offering therapeutic potential.
Purpose Of The Study
- To evaluate the efficacy and mechanisms of the novel HDAC inhibitor M344 against neuroblastoma.
- To compare M344 with vorinostat, a clinically used HDAC inhibitor.
- To assess M344's potential in combination therapies for neuroblastoma.
Main Methods
- Analysis of clinical neuroblastoma Gene Expression Omnibus data to correlate HDAC expression with tumor stage.
- In vitro assessment of M344's effects on histone acetylation, cell cycle, and apoptosis.
- In vivo studies using M344 in xenograft models and combination therapies with topotecan and cyclophosphamide.
Main Results
- Advanced-stage NB tumors showed higher HDAC expression.
- M344 increased histone acetylation, induced G0/G1 cell cycle arrest, and activated caspase-mediated cell death.
- M344 demonstrated superior cytostatic, cytotoxic, and migration-inhibitory effects compared to vorinostat.
- In vivo, M344 suppressed tumor growth and extended survival.
- Combination therapies with M344 improved tolerability and reduced tumor rebound.
Conclusions
- M344 exhibits significant therapeutic potential for neuroblastoma treatment.
- M344 offers improved tumor suppression and reduced off-target toxicities.
- Further investigation of M344 as a clinical candidate for neuroblastoma is warranted.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...